This analysis examines state Medicaid coverage of routine HIV screening and finds that currently, more than two thirds of states cover routine screening under their Medicaid programs. The analysis includes a breakdown of which states cover routine screening and which states only cover medically necessary HIV screening.
HIV/AIDSSee more about HIV/AIDS
- view as grid
- view as list
This fact sheet provides current information about state AIDS Drug Assistance Programs (ADAPs), which provide HIV medications to low-income people with HIV/AIDS who have limited or no prescription drug coverage.
This fact sheet examines the key role played by the United States in the Global Fund, an independent, multilateral financing entity designed to raise significant new resources to combat HIV/AIDS, tuberculosis (TB), and malaria in low- and middle- income countries.
Fact Sheet: What Are HIV Prevention Needs of Adults Over 50?
Latinos and HIV/AIDS (Spanish version)This fact sheet provides an overview of the HIV/AIDS epidemic in the United States as it has affected Latinos, including information on the disproportionate impact of HIV/AIDS on the Latino community and a current case profile. It is available in English and Spanish.Fact Sheet:
This updated fact sheet highlights the impact of HIV/AIDS on women in the United States, providing current data and trends over time.
Medicaid, the largest public health insurance program in the United States, covering health and long-term care services for more than 72 million low-income individuals, has played a critical role in HIV care since the HIV epidemic began. This fact sheet provides an overview of the role of each program for people with HIV, including trends and characteristics of beneficiaries, spending, services and other issues.
Reauthorization of PEPFAR, The United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Act: A Side-by-Side Comparison to Prior Law
This side-by-side compares key provisions of the 2008 PEPFAR reauthorization and the 2003 original law, which both relate to U.S. funding for global HIV/AIDS, tuberculosis, and malaria.